BDBM734293 (R)-5-(7-(2-aminoethyl)-1-fluoro-3-hydroxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide and (S)-5-(7-(2-aminoethyl)-1-fluoro-3-hydroxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide::US20250129032, Example 1

SMILES NCC[C@@H]1CCc2cc(O)c(N3CC(=O)NS3(=O)=O)c(F)c2CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 734293   

TargetReceptor-type tyrosine-protein phosphatase N2(Human)
Nerio Therapeutics

US Patent
LigandPNGBDBM734293((R)-5-(7-(2-aminoethyl)-1-fluoro-3-hydroxy-6,7,8,9...)
Affinity DataIC50: 5.07nMAssay Description:Compound activity was determined in an in vitro enzymatic assay using untagged, full-length human PTPN2 (TC45) (1-387) protein. PTPN2 was produced in...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent